mitral doppler
Diagnostic TestMitral doppler before and after vascular filling
NCT Number: NCT03447366
Interventional study of the accuracy of a non-invasive testing by echocardiography to predict respiratory worsening after vascular filling.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Ch Bourg En Bresse, Bourg-en-Bresse, France
Mitral Doppler will be performed before vascular filling. Patients will be classified in two groups (normal or high cardiac filling pressure).
The evolution of the respiratory data (SpO2/FiO2) of the two groups of the patients before and after vascular filling will be compared.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Mitral doppler before and after vascular filling
Time frame: 30 minutes after vascular filling
definied by a reduction of at least 15% of the SpO2/FiO2 ratio in the 30min following the vascular filling
Centre Hospitalier Metropole Savoie
Other
Assessment of Mitral Doppler as a Predictor of Respiratory Worsening After Vascular Filling for ICU Patients With Mechanical Ventilation. The EVALDM Study
Acronym: EVALDM
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06261619
Airway Management, Pathologic Processes
Providence, Rhode Island, United States
View Trial DetailsNCT03195127
Chronic Disease, Critical Illness
Baltimore, Maryland, United States
View Trial DetailsNCT02842944
Pathologic Processes, Pathological Conditions, Signs and Symptoms
Amiens, France
View Trial DetailsNCT02723565
Acute Respiratory Failure, Pathologic Processes
Toronto, Ontario, Canada
View Trial Details